In non-melanoma skin cancer, prognostic factors and the role of adjuvant radiation therapy: Retrospective, a single-center experience

Canyilmaz, Emine

doi:10.5455/annalsmedres.2023.03.068

In non-melanoma skin cancer, prognostic factors and the role of adjuvant radiation therapy: Retrospective, a single-center experience

Emine CANYILMAZ (Karadeniz Teknik Üniversitesi, Tıp Fakültesi, Radyasyon Onkolojisi Anabilim Dalı, Trabzon, Türkiye)

Annals of Medical Research

0 0

Yıl: 2023 Cilt: 30 Sayı: 4 Sayfa Aralığı: 513 - 519 Metin Dili: İngilizce DOI: 10.5455/annalsmedres.2023.03.068 İndeks Tarihi: 03-05-2023

In non-melanoma skin cancer, prognostic factors and the role of adjuvant radiation therapy: Retrospective, a single-center experience

Öz:

Aim: Non-melanoma skin cancer (NMSC) is the most prevalent malignancy worldwide, with basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) representing the most common types of NMSC. In this retrospective analysis, patients with NMSC who had adjuvant radiotherapy (RT) had their treatment results and prognostic variables evaluated. Materials and Methods: A total of 115 patients with NMSC who had adjuvant RT in our clinic during January 2006 and September 2021 were assessed. The average age was 74 years, and the male to female ratio was 1.95:1. (range: 25–95). The most often diagnosed kind of NMSC was SCC (93%, n=107), preceded by BCC (7%, n=8). The extremities (17.4%, n=20), the trunk (1.7%, n=2), and the head and neck area (80.9%, n=93) were where the bulk of NMSC lesions were discovered. Results: The mean follow-up period was 60.7 months (the range was 4.2–194.7); metas tases were found in six patients (5.2%), and locoregional recurrence was identified in 24 patients (20.8%). The 3- and 5-year total survival percentages were 71.2% and 59.3%, respectively, and the median overall survival (OS) time was 87.1 months. Tumor size and surgical margin status were linked to a worse OS in multivariate analysis of prognos tic variables (hazard rate [HR]=3.0, 95% confidence interval [CI]: 1.8-5.2; p=0.001 and HR=2.4, 95% CI: 1.4-4.1; p=0.002, respectively). Conclusion: Postoperative RT is an efficient, acceptable therapeutic option for NMSC in high-risk individuals. Our results suggest that surgical margin and tumor size were independent predictors of OS in NMSC patients; nevertheless, future studies including more patients are required to corroborate these results.

Anahtar Kelime: Skin cancer Squamous cell carcinoma Basal cell carcinoma Radiotherapy

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Young C. Solar ultraviolet radiation and skin cancer. Occup Med (Lond) 2009;59:82-8.
2. de Vries E, van de Poll-Franse LV, Louwman WJ, de Gruijl FR, Coebergh JW. Predictions of skin cancer incidence in the Nether lands up to 2015. Br J Dermatol 2005; 152: 481-8.
3. Ciążyńska M, Kamińska-Winciorek G, Lange D, Lewandowski B, Reich A, Sławińska M, et al., et al. The incidence and clinical analysis of non-melanoma skin cancer. Sci Rep 2021; 11: 4337.
4. Diepgen T, Mahler V. The epidemiology of skin cancer. Br J Dermatol 2002;146:1-6.
5. Fransen M, Karahalios A, Sharma N, English DR, Giles GG, Sin clair RD. Non-melanoma skin cancer in Australia. Med J Aust 2012; 197: 565-8.
6. Alam M, Ratner D. Cutaneous squamous-cell carcinoma. N Engl J Med 2001; 344: 975-983.
7. Likhacheva A, Awan M, Barker CA, Bhatnagar A, Bradfield L, Brady MS,et al.Definitive and Postoperative Radiation Therapy for Basal and Squamous Cell Cancers of the Skin: Executive Summary of an American Society for Radiation Oncology Clin ical Practice Guideline. Pract Radiat Oncol 2020; 10: 8-20.
8. Avril MF, Auperin A, Margulis A, Gerbaulet A, Duvillard P, Benhamou E, et al. Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study. Br J Cancer 1997; 76: 100-6.
9. Strom T, Harrison LB. Radiotherapy for management of basal and squamous cell carcinoma. Curr Probl Cancer 2015; 39: 237- 247.
10. Eisemann N, Waldmann A, Geller AC, Weinstock MA, Volkmer B, Greinert R, et al. Nonmelanoma skin cancer incidence and impact of skin cancer screening on incidence. J Invest Dermatol 2014; 134: 43-50.
11. Sinclair C, Foley P. Skin cancer prevention in Australia Br J Dermatol 2009; 161 Suppl 3: 16-123.
12. Jackson JE, Dickie GJ, Wiltshire KL, Keller J, Tripcony L, Poulsen MG, et al. Radiotherapy for perineural invasion in cu taneous head and neck carcinomas: toward a risk-adapted treat ment approach. Head Neck 2009; 31: 604-10.
13. Zanetti R, Rosso S, Martinez C, et al. The multicentre south European study ’Helios’. I: skin characteristics and sunburns in basal cell and squamous cell carcinomas of the skin. Br J Cancer 1996; 73: 1440-6.
14. Gallagher RP, Ma B, McLean DI, et al. Trends in basal cell carcinoma, squamous cell carcinoma, and melanoma of the skin from 1973 through 1987. J Am Acad Dermatol 1990; 23: 413-21.
15. Aguilar Bernier M, Rivas Ruiz F, De Troya Martin M, Blazquez Sanchez N. Comparative epidemiological study of non-melanoma skin cancer between Spanish and north and central European residents on the Costa del Sol. J Eur Acad Dermatol 2012; 26: 41-7.
16. Scrivener Y, Grosshans E, Cribier B. Variations of basal cell car cinomas according to gender, age, location and histopathological subtype. Br J Dermatol 2002; 147: 41–7.
17. Liu FF, Maki E, Warde P, et al. A management approach to in completely excised basal cell carcinomas of the skin. Int J Radiat Oncol Biol Phys 1991; 20: 423–8.
18. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022; 72: 7–33.
19. Likhacheva A, Awan M, Barker CA, et al. Definitive and Postop erative Radiation Therapy for Basal and Squamous Cell Cancers of the Skin: Executive Summary of an American Society for Radiation Oncology Clinical Practice Guideline. Pract Radiat Oncol 2020; 10: 8-20.
20. Muto P and Pastore F. Radiotherapy in the Adjuvant and Advanced Setting of CSCC. Dermatol Pract Concept 2021; 11(Suppl 2): e2021168S.
21. Harris BN, Bayoumi A, Bewley AF, et al. Factors associated with recurrence and regional adenopathy for head and neck cutaneous squamous cell carcinoma. Otolaryngol Head Neck Surg. 2017; 156: 863-869.
22. Strassen U, Hofauer B, Jacobi C, Knopf A. Management of lo coregional recurrence in cutaneous squamous cell carcinoma of the head and neck. Eur Arch Oto-Rhino-Laryngol Off J Eur Fed Oto-Rhino-Laryngol Soc EUFOS Affil Ger Soc Oto-Rhino Laryngol – Head Neck Surg 2017; 274 :501-6.
23. Kim SK, Barker CA. Outcomes of radiation therapy for ad vanced T3/T4 nonmelanoma cutaneous squamous cell and basal cell carcinoma. Br J Dermatol 2018;178(1):e30-2.
24. Eisemann N, Jansen L, Castro FA, et al, GEKID Cancer Sur vival Working Group Survival with non-melanoma skin cancer in Germany. Br J Dermatol 2016; 174 :778-785.
25. Hollestein LM, de Vries E, Nijsten T. Trends of cutaneous squa mous cell carcinoma in the Netherlands: increased incidence rates, but stable relative survival and mortality 1989-2008. Eur J Cancer 2012; 48: 2046-2053.
26. Liu FF, Maki E, Warde P, et al. A management approach to in completely excised basal cell carcinomas of the skin. Int J Radiat Oncol Biol Phys 1991; 20: 423-8.
27. Mendenhall WM, Amdur RJ, Williams L Set al. Carcinoma of the skin of the head and neck with perineural invasion. Head Neck 2002; 24: 78-83.
28. Hanke CW, Wolf RI, Hochman SA, O’Brian JJ. Chemosurgical reports: Perineural spread of basal cell carcinoma. J Dermatol Surg Oncol 1983; 9: 742-7.
29. Mohs FE, Lathrop TG. Modes of spread of cancer of skin. Arch Dermatol Syphilol 1952; 66: 427-39.
30. Leibovitch I, Huilgol SC, Selva D, et al. Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia II. Perineural invasion. J Am Acad Dermatol 2005; 53: 261-266.
31. Leibovitch I, Huilgol SC, Selva D, et al. Basal cell carcinoma treated with Mohs surgery in Australia III. Perineural invasion. J Am Acad Dermatol 2005; 53: 458-463.
32. Kyrgidis A, Tzellos TG, Kechagias N, et al. Cutaneous Squa mous Cell Carcinoma (SCC) of the Head and Neck: Risk Fac tors of Overall and Recurrence-Free Survival. European Journal of Cancer 2010; 46: 1563-1572.
33. Que SKT, Zwald FO, Schmults CD. Cutaneous squamous cell carcinoma: Incidence, risk factors, diagnosis, and staging. J Am Acad Dermatol 2018; 78: 237-247.
34. Thompson AK, Kelley BF, Prokop LJ, et al. Risk factors for cutaneous squamous cell carcinoma recurrence, metastasis, and disease-specific death: a systematic review and meta-analysis. JAMA Dermatol 2016; 152: 419-28.
35. Brantsch KD, Meisner C, Schonfisch B, et al. Analysis of risk factors determining prognosis of cutaneous squamous cell carci noma: a prospective study. Lancet Oncol. 2008; 9: 713-720.
36. Mullen JT, Feng L, Xing Y, et al. Invasive squamous cell carci noma of the skin: defining a high-risk group. Annals of Surgical Oncology 2006; 13: 902-909.
37. Clayman GL, Lee JJ, Holsinger FC, et al. Mortality risk from squamous cell skin cancer. J Clin Oncol. 2005; 23: 759-65.

APA	Canyilmaz E (2023). In non-melanoma skin cancer, prognostic factors and the role of adjuvant radiation therapy: Retrospective, a single-center experience. , 513 - 519. 10.5455/annalsmedres.2023.03.068
Chicago	Canyilmaz Emine In non-melanoma skin cancer, prognostic factors and the role of adjuvant radiation therapy: Retrospective, a single-center experience. (2023): 513 - 519. 10.5455/annalsmedres.2023.03.068
MLA	Canyilmaz Emine In non-melanoma skin cancer, prognostic factors and the role of adjuvant radiation therapy: Retrospective, a single-center experience. , 2023, ss.513 - 519. 10.5455/annalsmedres.2023.03.068
AMA	Canyilmaz E In non-melanoma skin cancer, prognostic factors and the role of adjuvant radiation therapy: Retrospective, a single-center experience. . 2023; 513 - 519. 10.5455/annalsmedres.2023.03.068
Vancouver	Canyilmaz E In non-melanoma skin cancer, prognostic factors and the role of adjuvant radiation therapy: Retrospective, a single-center experience. . 2023; 513 - 519. 10.5455/annalsmedres.2023.03.068
IEEE	Canyilmaz E "In non-melanoma skin cancer, prognostic factors and the role of adjuvant radiation therapy: Retrospective, a single-center experience." , ss.513 - 519, 2023. 10.5455/annalsmedres.2023.03.068
ISNAD	Canyilmaz, Emine. "In non-melanoma skin cancer, prognostic factors and the role of adjuvant radiation therapy: Retrospective, a single-center experience". (2023), 513-519. https://doi.org/10.5455/annalsmedres.2023.03.068

APA	Canyilmaz E (2023). In non-melanoma skin cancer, prognostic factors and the role of adjuvant radiation therapy: Retrospective, a single-center experience. Annals of Medical Research, 30(4), 513 - 519. 10.5455/annalsmedres.2023.03.068
Chicago	Canyilmaz Emine In non-melanoma skin cancer, prognostic factors and the role of adjuvant radiation therapy: Retrospective, a single-center experience. Annals of Medical Research 30, no.4 (2023): 513 - 519. 10.5455/annalsmedres.2023.03.068
MLA	Canyilmaz Emine In non-melanoma skin cancer, prognostic factors and the role of adjuvant radiation therapy: Retrospective, a single-center experience. Annals of Medical Research, vol.30, no.4, 2023, ss.513 - 519. 10.5455/annalsmedres.2023.03.068
AMA	Canyilmaz E In non-melanoma skin cancer, prognostic factors and the role of adjuvant radiation therapy: Retrospective, a single-center experience. Annals of Medical Research. 2023; 30(4): 513 - 519. 10.5455/annalsmedres.2023.03.068
Vancouver	Canyilmaz E In non-melanoma skin cancer, prognostic factors and the role of adjuvant radiation therapy: Retrospective, a single-center experience. Annals of Medical Research. 2023; 30(4): 513 - 519. 10.5455/annalsmedres.2023.03.068
IEEE	Canyilmaz E "In non-melanoma skin cancer, prognostic factors and the role of adjuvant radiation therapy: Retrospective, a single-center experience." Annals of Medical Research, 30, ss.513 - 519, 2023. 10.5455/annalsmedres.2023.03.068
ISNAD	Canyilmaz, Emine. "In non-melanoma skin cancer, prognostic factors and the role of adjuvant radiation therapy: Retrospective, a single-center experience". Annals of Medical Research 30/4 (2023), 513-519. https://doi.org/10.5455/annalsmedres.2023.03.068